- Designed for the Sofia® and Sofia® 2 Analyzers, it is a rapid, point-of-care fluorescent immunoassay used to detect Borrelia burgdorferi (the bacteria that causes Lyme disease
Uses
- Differential Detection:
- Simultaneously differentiates between human IgM and IgG antibodies to Borrelia burgdorferi in a single test
- Patient Diagnosis:
- Aids clinicians in evaluating patients with suspected recent or past Lyme disease infections using serum or plasma samples
Features
- Rapid Turnaround:
- Provides fully automated and objective results in just 10 minutes
- User-Friendly Cassettes:
- Utilizes a self-contained test cassette designed for clean usage, minimal handling, and straightforward disposal
- Objective Analysis:
- Minimizes visual reading errors by using the Sofia® instrument to interpret the fluorescent signal and deliver standardized, printed, or digital results
Benefits
- Actionable Workflows:
- The 10-minute turnaround time allows clinics to perform rapid Lyme testing at the point of care, avoiding the delays of sending samples to off-site laboratories
- Improved Patient Care:
- Rapid IgM and IgG differentiation helps determine the stage of the infection (recent vs. past exposure) to quickly inform appropriate treatment pathways
- Workflow Efficiency:
- Easy-to-use cassettes and automated analyzer interpretations help labs maintain high throughput even with staffing limitations